↓ Skip to main content

Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report

Overview of attention for article published in Antimicrobial Resistance & Infection Control, February 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report
Published in
Antimicrobial Resistance & Infection Control, February 2018
DOI 10.1186/s13756-018-0313-5
Pubmed ID
Authors

Wei Guo, Shao-Chun Guo, Min Li, Li-Hong Li, Yan Qu

Abstract

Acinetobacter baumannii nosocomial ventriculitis/meningitis, especially those due to drug-resistant strains, has substantially increased over recent years. However, limited therapeutic options exist for theAcinetobacter baumanniiventriculitis/meningitis because of the poor penetration rate of most antibiotics through the blood-brain barrier. A 57-year-old male patient developed ventriculitis from an extensively drug-resistant strain ofAcinetobacter baumanniiafter the decompressive craniectomy for severe traumatic brain injury. The patient was successfully treated with intraventricular and intravenous polymyxin B together with intravenous tigecycline. The case illustrates intraventricular polymyxin B can be a therapeutic option against extensively drug-resistantAcinetobacter baumanniiventriculitis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 26%
Researcher 3 16%
Student > Doctoral Student 2 11%
Student > Ph. D. Student 1 5%
Unknown 8 42%
Readers by discipline Count As %
Medicine and Dentistry 4 21%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Neuroscience 2 11%
Nursing and Health Professions 1 5%
Agricultural and Biological Sciences 1 5%
Other 1 5%
Unknown 8 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2018.
All research outputs
#14,608,019
of 24,003,070 outputs
Outputs from Antimicrobial Resistance & Infection Control
#895
of 1,347 outputs
Outputs of similar age
#238,303
of 452,602 outputs
Outputs of similar age from Antimicrobial Resistance & Infection Control
#36
of 45 outputs
Altmetric has tracked 24,003,070 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,347 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 452,602 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.